Inherent β-Cell Dysfunction Induced by Transgenic Expression of Allogeneic Major Histocompatibility Complex Class I Antigen in Islet Cells

References

• Allison J, Campbell I L, Morahan G, Mandel T E, Harrison L C, Miller J FAP. Diabetes in transgenic mice resulting from over-expression of class I histocompatability molecules in pancreatic B cells. Nature 1988; 333: 529–533
   PubMed Web of Science ®Google Scholar
• Sarvetnick N, Liggitt D, Pitts S L, Hansen S E, Stewart T A. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988; 52: 773–782
   PubMed Web of Science ®Google Scholar
• Lo D, Burkly L C, Widera G, Cowing C, Flavell R A, Palmiter R D, Brinster R L. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 1988; 53: 159–168
   PubMed Web of Science ®Google Scholar
• Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Exp Anim 1980; 1: 1–13
   Google Scholar
• Fujita T, Yui R, Kusumoto Y, Serizawa Y, Makino S, Tochino Y. Lymphocytic insulitis in a “Non-Obese Diabetic (NOD)” strain of mice: an immunohistochemical and electron miscroscope investigation. Biochem Res 1980; 3: 429–443
   Google Scholar
• Kanazawa K, Komeda K, Sato S, Mori S, Akanuma K, Takaku F. Non-obese-diabetic mice: immune mechanisms of pancreatic B cell destruction. Diabetologia 1984; 27: 113–115
   PubMedGoogle Scholar
• Nakhooda A F, Like A A, Chappel C I, Murray F T, Marliss E B. The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes 1977; 26: 100–112
   PubMed Web of Science ®Google Scholar
• Seemayer T A, Tannenbaum G S, Goldman H, Colle E. Dynamic time course studies of the spontaneously diabetic BB Wistar rat. III. Light microscopy and ultrastructural ohservations of pancreatic islets of Langerhans. Amer J Pathol 1982; 106: 237–249
   PubMed Web of Science ®Google Scholar
• Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619–633
   PubMed Web of Science ®Google Scholar
• Junker K, Egeberg J, Kromann H, Nerup J. An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand Sect A 1977; 85: 699–706
   PubMedGoogle Scholar
• Foulis A K, Liddle C N, Farquharson M A, Richmond J A, Weir R S. The histopathology of the pancreas in Type I (in sulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986; 29: 267–214
   PubMed Web of Science ®Google Scholar
• Epstein P N, Overbeek P A, Means A R. Calmodulin-induced early-onset diabetes in transgenic mice. Cell 1989; 58: 1067–1073
   PubMedGoogle Scholar
• Efran S, Fleischer N, Hanahan D. Diabetes induced in male transgenic mice by expression of human H-ras oncoprotein in pancreatic β cells. Molec Cell Biol 1990; 10: 1779–1783
   PubMedGoogle Scholar
• Drell D W, Notkins A L. Multiple immunological abnormalities in patients with Type I (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 132–143
   PubMed Web of Science ®Google Scholar
• Laupacis A, Stiller C R, Gardell L C, Keown P, Dupre J, Wallace A C, Thibert P. Cyclosporin prevents diabetes in BB Wistar rats. Lancey 1983; 21: 10–11
   Google Scholar
• Rossini A A, Faustman D, Woda B A, Like A A, Szymanski I, Mordes J P. Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester Rat. J Clin Invest 1984; 74: 39–46
   PubMed Web of Science ®Google Scholar
• Hahn H J, Lucke S, Kloting I, Volk H D, Baehr R V, Diamanstein T. Curing BB rats of freshly manifested diabetes by short- term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cy closporin A. Eur J Immunol 1987; 17: 1075–1078
   PubMed Web of Science ®Google Scholar
• Mordes J P, Gallina D L, Handler E S, Greiner D L, Nakamura N, Pelletier A, Rossini A A. Transfusions enriched for W3/25+ helper/inducer T lymphocytes prevent spontaneous diabetes in the BB/W rat. Diabetologia 1987; 30: 22–26
   PubMed Web of Science ®Google Scholar
• Mori Y, Suko M, Okudaira H, Matsuba I, Tsuruoka A, Sasaki A, Yokoyama H, Tanase T, Shida T, Nishimura M, Terada E, Ikeda Y. Preventive effects of Cyclosporin on diabetes in NOD mice. Diabetologia 1986; 29: 244–247
   PubMedGoogle Scholar
• Shizuru J A, Taylor-Edwards C, Banks B A, Gregory A K, Fathman C G. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 1988; 240: 659–662
   PubMed Web of Science ®Google Scholar
• Charlton B, Bacelj A, Mandel T E. Administration of silica particles or anti-Lyt2 antibody prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes 1988; 37: 930–935
   PubMed Web of Science ®Google Scholar
• Charlton B, Mandel T E. Progression from insulitis to β-cell destruction in NOD mouse requires L3T4+ T-lymphocytes. Diabetes 1988; 37: 1108–112
   PubMed Web of Science ®Google Scholar
• Elliott R B, Crossley J R, Berryman C C, James A G. Partial preservation of pancreatic B cell function in children with diabetes. Lancet 1981; 11: 1–4
   Google Scholar
• Stiller C R, Dupre J, Gent M, Jenner M R, Keown P A, Laupacis A, Martell R, Rodger N W. Graffenried Bv Wolfe BMJ: Effects of Cyclosporin immunosuppression in insulin- dependent diabetes mellitus of recent onset. Science 1984; 223: 1362–1367
   PubMed Web of Science ®Google Scholar
• Feutren G, Papoz L, Assan R, Vialetes B, Karsenty G, Vexiau P, DuRostu H, Rodier M, Sirmai J, Lallemand A, Bach J -F. Cyclosporin increases the rate and length of remission in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet 1986; 11: 119–124
   Google Scholar
• The Canadian-European Randomized Control Trial Group. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. Diabetes 1988; 37: 1574–1582
   PubMed Web of Science ®Google Scholar
• Morahan G, Allison J, Miller J FAP. Tolerance of class I histocompatibility antigens expressed extrathymicaly. Nature 1989; 339: 622–624
   PubMed Web of Science ®Google Scholar
• Theiler K. The house mouse: development and normal stage. from fertilization to four weeks of age. Springer Verlag, Heidelberg 1972
   Google Scholar
• Mandel T E, Kennedy M M. The differentiation of murine thymocytes in vivo and in vitro. Immunology 1978; 35: 317–331
   PubMedGoogle Scholar
• Mandel T E, Hoffman L, Collier S A, Carter W M, Koulmanda M. Organ culture of fetal mouse and fetal human pancreatic islets for allografting. Diabetes 1982; 31(suppl 4)39–47
   PubMedGoogle Scholar
• Morgan C R, Lazarow A. Immunoassay of insulin. Two antibody systems. Plasma levels of normal, subdiabetic and diabetic rats. Diabetes 1963; 12: 115–126
   Web of Science ®Google Scholar
• Collier S A, Mandel T E, Hoffman L, Caruso G. Organ culture of fetal mouse pancreas: the effect of various culture conditions on insulin secretion. Diabetes 1982; 30: 804–812
   Google Scholar
• Mandel T E, Koulmanda M. Effect of ischemia and tem perature on fetal mouse pancreas. Insulin production in vitro, and function after isotransplantation. Diabetes 1984; 33: 376–382
   PubMedGoogle Scholar
• Mandel T E, Koulmanda M. Effect of culture conditions on fetal mouse pancreas in vitro and after transplantation in syngeneic and allogeneic recipients. Diabetes 1985; 34: 1082–1087
   PubMedGoogle Scholar
• Bonner-Weir S, Trent D, Weir G C. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest 1983; 71: 1544–1553
   PubMed Web of Science ®Google Scholar
• Parham P. Intolerable secretion in tolerant transgenic mice. Nature 1988; 333: 500–503
   PubMed Web of Science ®Google Scholar
• Foulis A K, Farquharson M A, Hardman R. Aberrant expression of Class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 333–343
   PubMed Web of Science ®Google Scholar
• Leiter E H, Prochazka M, Schultz L D. Effect of immunodeficiency on diabetogenesis in genetically diabetic (db/db) mice. J Immunol 1987; 138: 3224–3229
   PubMedGoogle Scholar
• Leiter E H. Type C retrovirus production by pancreatic Beta cells. Association with accelerated pathogenesis in C3H-db/db (“Diabetes”) mice. Amer J Pathol 1985; 119: 22–32
   PubMed Web of Science ®Google Scholar
• Suenaga K, Yoon J -W. Association of β cell-specific expression of endogenous retrovirus with development of insulitis and diabetes in NOD mouse. Diabetes 1988; 37: 1722–1726
   PubMed Web of Science ®Google Scholar
• Serreze D V, Leiter E H, Kuff E L, Jardieu P, Ishizaka K. Molecular mimicry between insulin and retroviral antigen p 73. Development of cross-reactive autoantibodies in sera of NOD and C57BL/KsJ db/db mice. Diabetes 1988; 37: 351–358
   PubMed Web of Science ®Google Scholar